Pacegenix

Private

Cambridge, MassachusettsEnterprise Softwarehttps://pacegenix.com/

Last Round

Early Stage

Mar 26, 2026

Company Overview

Pacegenix is a biotechnology company that develops precision cardiology therapeutics designed to treat heart rhythm disorders and improve outcomes in patients with complex arrhythmias.

Sector

Enterprise Software

Verticals

Cloud Infrastructure, Workflow Automation, DevOps & Containers

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

custom software developmentIT consultingdigital transformationmanaged IT servicessoftware engineeringIT outsourcingapplication engineeringinfrastructure supportprocess modernizationtech advisorysoftware housemanaged services providerMSPdigital agency

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pacegenix Comps

Public and private peers based on sector, stage, and business model.

Pacegenix comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pacegenix Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Stage VC	Mar 26, 2026

View all Funding Rounds

Pacegenix Investors

Notable investors and investment history

Pacegenix investors
Investor	Rounds
Genesis BioCapital	Early Stage VC, Accelerator
Eshelman Ventures	Early Stage VC
aMoon	Early Stage VC
LDV Partners	Early Stage VC

View all Investors

Pacegenix Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pacegenix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pacegenix's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Year Founded2024

Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.